Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

MMAIA Biotechnology, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
M

MAIA Biotechnology, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions

News

News

  • MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal
    Sep 23, 2026MAIA Biotechnology, Inc. (MAIA) Press Releases
  • MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer
    Sep 22, 2026MAIA Biotechnology, Inc. (MAIA) Press Releases
  • MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial
    Sep 16, 2026MAIA Biotechnology, Inc. (MAIA) Press Releases
  • MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO
    Sep 15, 2026MAIA Biotechnology, Inc. (MAIA) Press Releases
  • MAIA Biotechnology Delivers Oral and Poster Presentations Showcasing Next-Generation Telomere-Targeting Cancer Therapies at IRT 2026
    Sep 10, 2026MAIA Biotechnology, Inc. (MAIA) Press Releases
  • MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial
    Jul 8, 2026MAIA Biotechnology, Inc. (MAIA) Press Releases
  • MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer
    Jun 25, 2026MAIA Biotechnology, Inc. (MAIA) Press Releases
  • MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
    Jun 18, 2026MAIA Biotechnology, Inc. (MAIA) Press Releases
  • MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial
    Jun 10, 2026MAIA Biotechnology, Inc. (MAIA) Press Releases
  • MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial
    Jun 4, 2026MAIA Biotechnology, Inc. (MAIA) Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • News
  • Insider Transactions